1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Recurrent Hematologic Malignancy: new trials by email Literature Review of Recurrent Hematologic Malignancy trials Research Report on Recurrent Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial Abemaciclib, Abiraterone, Afatinib - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Terminated | OHSU Knight Cancer Institute | 2 | 2020-04-01 | 2024-03-04 |
Anemia (1) · Blast Crisis (1) · Breast Neoplasms (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myeloid, Chronic-Phase (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1)
Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Breast Diseases (1) · Carcinogenesis (1) · Cardiovascular Diseases (1) · Cell Transformation, Neoplastic (1) · Chronic Disease (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genital Diseases (1) · Genital Diseases, Male (1)
130-nm albumin-bound paclitaxel (1) · 2C4 antibody (1) · Ado-Trastuzumab Emtansine (1) · Afatinib (1) · Albumin-Bound Paclitaxel (1) · Bevacizumab (1) · Bortezomib (1) · CTLA-4 Antigen (1) · Capecitabine (1) · Carboplatin (1) · Celecoxib (1) · Dasatinib (1) · Disulfides (1) · Doxorubicin (1) · Erlotinib Hydrochloride (1)
OHSU Knight Cancer Institute (1)
United States (1)
Lara Davis, MD (1)